ProShare Advisors LLC Increases Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

ProShare Advisors LLC raised its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 49.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,260 shares of the company’s stock after acquiring an additional 6,672 shares during the period. ProShare Advisors LLC’s holdings in Surgery Partners were worth $482,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. DekaBank Deutsche Girozentrale boosted its stake in Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after purchasing an additional 1,375 shares in the last quarter. EntryPoint Capital LLC lifted its stake in shares of Surgery Partners by 257.1% in the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after buying an additional 4,607 shares in the last quarter. Capstone Investment Advisors LLC purchased a new stake in shares of Surgery Partners during the fourth quarter valued at approximately $211,000. MeadowBrook Investment Advisors LLC increased its position in shares of Surgery Partners by 15.9% during the second quarter. MeadowBrook Investment Advisors LLC now owns 12,320 shares of the company’s stock valued at $293,000 after acquiring an additional 1,690 shares in the last quarter. Finally, Natixis Advisors LLC increased its position in shares of Surgery Partners by 11.0% during the second quarter. Natixis Advisors LLC now owns 12,452 shares of the company’s stock valued at $296,000 after acquiring an additional 1,237 shares in the last quarter.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY opened at $32.24 on Tuesday. The firm’s 50 day moving average price is $30.62 and its 200-day moving average price is $27.64. The company has a quick ratio of 1.69, a current ratio of 1.83 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $4.10 billion, a PE ratio of 45.37, a price-to-earnings-growth ratio of 2.50 and a beta of 2.76. Surgery Partners, Inc. has a twelve month low of $22.05 and a twelve month high of $36.92.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The business had revenue of $762.10 million for the quarter, compared to the consensus estimate of $735.94 million. During the same period last year, the firm earned $0.25 earnings per share. The company’s quarterly revenue was up 14.2% on a year-over-year basis. Equities research analysts expect that Surgery Partners, Inc. will post 0.86 EPS for the current year.

Analyst Ratings Changes

Several research firms recently issued reports on SGRY. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $43.00 price objective on shares of Surgery Partners in a research report on Monday, August 19th. StockNews.com cut Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, August 7th. Royal Bank of Canada reissued an “outperform” rating and issued a $49.00 target price on shares of Surgery Partners in a research report on Wednesday, August 7th. Citigroup dropped their price target on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Finally, Macquarie started coverage on shares of Surgery Partners in a report on Friday, June 28th. They set an “outperform” rating and a $31.00 price objective for the company. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Surgery Partners has a consensus rating of “Moderate Buy” and a consensus target price of $39.86.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.